mpox vaccine candidate reduces disease severity in primates
04 October, 2024A vaccine candidate from Moderna more effectively limits symptoms and disease duration in primates that were infected with a lethal strain of the mpox virus when compared to a currently licensed MVA vaccine.
Shared cellular mechanisms found across three major dementias
02 October, 2024Researchers have identified degeneration-associated 'molecular markers' that are shared by several forms of dementia, as well as markers specific to different forms of dementia.
More Australians now eligible for free shingles vaccine
01 October, 2024The free shingles vaccination is now available to more Australians over 18 who are immunocompromised due to an underlying health condition or as a side effect of treatment.
Pioneer bacteria analysed in newborns' microbiomes
19 September, 2024In the largest known study of UK baby microbiomes to date, researchers have discovered that newborn babies have one of three pioneer bacteria in their gut shortly after birth.
How the aging immune system fuels cancer growth
17 September, 2024New research reveals how an aging immune system spurs tumour growth, offering new insights into cancer prevention and treatment — especially for older adults.
Finding and blocking the mechanism behind allergic itching
13 September, 2024New research provides an explanation for why, in a world full of allergens, one person may be more likely to develop an allergic response than another.
Psychotic disorders linked to brain network organisation
11 September, 2024Cognitive impairments in psychotic disorders, such as schizophrenia and bipolar disorder, are linked to brain network organisation.
Lab-grown blood stem cells could be used for transplants
09 September, 2024Researchers have overcome a major hurdle for producing blood stem cells — which can create red blood cells, white blood cells and platelets — that closely match those in the human embryo.
Are immune cells focused on the wrong part of the flu vaccine?
03 September, 2024Scientists say they have discovered why the flu vaccine can perform poorly, having found that a specific type of immune cell indirectly controls the anti-influenza response.
How social drinking boosts euphoria
23 August, 2024Grab a drink with friends at happy hour and you're likely to feel chatty, friendly and upbeat, but grab a drink alone and you may experience feelings of depression.
Neuropeptides found to encode danger in the brain
15 August, 2024The process of translating pain into a 'threat memory' occurs so quickly that scientists originally thought it must be mediated by fast-acting neurotransmitters, but it turns out this is not the case.
Brain pathway found for placebo pain relief
13 August, 2024The pain control pathway is crucial to placebo analgesia — where the expectation of pain relief leads to pain alleviation without therapeutic intervention.
Potent immune cells found in the vicinity of glioblastomas
12 August, 2024Highly potent immune cells gather in regional bone marrow niches close to the glioblastoma tumour and organise the defence from there.
Autoantibodies cause lifelong susceptibility to viral infections
09 August, 2024About 2% of the population develop autoantibodies against type 1 interferons, mostly later in life, which makes individuals more susceptible to viral diseases like COVID-19.
Locating the origins of creativity in the brain
06 August, 2024Researchers have used a precise method of brain imaging to unveil how different parts of the brain work together in order to produce creative thought.
